An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Guangzhou Military Region General Hospital, Department of Anesthesiology, Guangzhou, Guangdong, China
St-Justine's Hospital, Montréal, Quebec, Canada
Assiut university hospital, Assiut, Egypt, Assiut, Assiut governorate, Egypt
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
Bambino Gesù Children's Hospital, Rome, Italy
Boston Children's Hospital, Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Texas Children's Hospital, Houston, Texas, United States
KK Women's and Children's Hospital, Singapore, Singapore
BC Children's Hospital - Department of Anesthesia, Vancouver, British Columbia, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.